Sartorius and BD Diagnostics plan to collaborate on ready-to-use, prefilled media products for microbiological applications.
Sartorius Stedim Biotech and BD Diagnostics, a segment of BD (Becton, Dickinson and Company) a medical technology company, reported a collaboration to develop, manufacture, and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech, and research laboratories.
As part of this collaboration, BD will fill special Sartorius single-use products with BD culture media and supply these to Sartorius as prepackaged products. Both companies are looking to further extend their existing business relationship by pursuing other solutions in the field of microbiological diagnostics.
Source: Sartorius Stedim Biotech
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.